Trials / Terminated
TerminatedNCT02601690
Observational Analysis of T Cell Responses to SPIREs for Multiple Allergens in Subjects With Allergy in North America
Observational, Cross-sectional Analysis of T Cell Responses to Synthetic Peptide Immuno-Regulatory Epitopes (SPIREs) for Multiple Allergens in Subjects With Allergy in North America
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 199 (actual)
- Sponsor
- Adiga Life Sciences, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a research study intending to look at the response of a specific type of allergy cells in the blood (called T cells) to a a type of immunotherapy product known as SPIREs (Synthetic Peptide Immuno-Regulatory Epitopes), across a broad range of subjects. This is a non-interventional study in which no investigational product will be administered to any subject.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood Sampling |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-06-25
- Completion
- 2017-06-25
- First posted
- 2015-11-10
- Last updated
- 2019-04-09
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02601690. Inclusion in this directory is not an endorsement.